https://www.fool.com/investing/2017/05/22/3-drug-stocks-billionaire-money-managers-dumped-bi.aspx?source=iedfolrf0000001
May 22, 2017 - Billionaires appear to have focused on drug stocks that were mired in debt in Q1.
4
fool:4870415540769129704
4
https://www.fool.com/investing/general/2017/06/05/is-ironwoods-growth-about-to-slow.aspx?source=iedfolrf0000001
Jun 05, 2017 - New competition could slow prescription growth for Linzess and take some of the luster off this small-cap biotech stock.
4
fool:6867626752026154686
4
https://www.fool.com/investing/2017/07/26/these-2-pharma-giants-may-be-on-pfizers-ma-radar-r.aspx?source=iedfolrf0000001
Jul 26, 2017 - Pfizer seems to be edging closer to a megadeal.
4
fool:-7821493635921163453
4
http://www.startribune.com/business/469830213.html
Jan 18, 2018 - Restaurant owners are especially worried about losing their vendor with little notice with the expected Super Bowl rush.
4
sb:-3353682412795908456
4
http://www.zacks.com/stock/news/260911/allergans-irritable-bowel-drug-viberzi-approved-in-canada?cid=CS-ZC-FT-260911
May 17, 2017 - Allergan plc (AGN) announced that Health Canada approved Viberzi (eluxadoline) for the treatment of adults suffering with irritable bowel syndrome with diarrhea (IBS-D)
3
zc:-7250043621967811230
3
https://seekingalpha.com/article/4071181-allergan-plc-agn-q1-2017-results-earnings-call-transcript?source=feed_sector_healthcare
May 09, 2017 - Allergan Plc (NYSE:AGN)Q1 2017 Earnings CallMay 09, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson - Allergan
3
sa:-1743824887841613389
3
http://www.zacks.com/stock/news/259797/the-top-earnings-charts-to-start-the-week?cid=CS-ZC-FT-259797
May 08, 2017 - With so many companies reporting earnings, Tracey wades through all the noise to bring you the best charts.
2
zc:-8921151086716634173
2
https://www.fool.com/investing/2017/04/23/should-gilead-sciences-be-worried-about-allergan.aspx?source=iedfolrf0000001
Apr 23, 2017 - Gilead Sciences might want to pay attention to Allergan's aggressive expansion of its NASH program.
2
fool:-3402600035961810023
2
https://www.fool.com/investing/2017/08/10/heres-why-synergy-pharmaceuticals-inc-is-falling-t.aspx?source=iedfolrf0000001
Aug 10, 2017 - Shares tumble after the company reports a higher-than-expected loss in the second quarter.
2
fool:7788771027655136303
2
https://www.fool.com/investing/2017/08/24/3-top-healthcare-stocks-to-buy-now.aspx?source=iedfolrf0000001
Aug 25, 2017 - This year's healthcare rally hasn't swept these quality stocks along with the rest of the sector. At least not yet.
2
fool:567710695979718027
2